No Data
Featured stock: A growth newcomer engaged in personal AI.
Ortz <260A.T> is a promising growth stock that is gaining high expectations for rise in the New Year's market. The company primarily offers SaaS (Software as a Service) products, such as the AI (Artificial Intelligence) minutes-making tool "AI GIJIROKU", and is also gaining attention for its research in personal AI. It went public in October last year. Unlike many other AI-related stocks that focus on solution services, it primarily operates in SaaS, and there is an acceptance of its current performance being in the red.
January 6 [Today's Investment Strategy]
Provides solutions for management consulting, M&A advisory, management execution support, business revitalization, and more.
Stocks that moved the previous day part 2: Kyogoku Unyu, GMO Ad Partners, Ise Chemical, ETC.
Stock Name <Code> Closing Price on the 26th ⇒ Change from Previous Day Fuji HD <4676> 1767.5 -91.5 Concern over the ripple effect of magazine articles. Kioxia HD <285A> 1590 -7425 Favorable return selling after significant rebound in recent days. Seed <7743> 551 -36 Continuing the declining trend after recent sharp price increase. Istyle <3660> 448 -19 Pressured by short-term funds' profit-taking selling. Appier Group <4180> 1479 -21 A sense of completion in the rebound.
Emerging Markets Stock Digest: Synbio Pharmaceuticals continues to fall, Business Coach temporarily hits the upper limit.
＜4263＞ Susmed 582 +7 rebound. It was announced that the operation of a clinical trial system (SUSMED SDS) utilizing Blockchain Technology was started in a doctor-led clinical trial at the National Center of Neurology and Psychiatry. This clinical trial targets patients with myalgic encephalomyelitis/chronic fatigue syndrome, aiming to verify the efficacy and safety of Rituximab. Utilizing SUSMED SDS, it aims to reduce monitoring tasks and improve the quality and reliability of the data obtained.
Hot Stocks Digest (Morning Session): Sekisui Chemical, J. Front, Towns, ETC.
Sekisui Chemical Co. (<4204>): 2,647.5 yen (+193.5 yen) showing significant continued growth. It has been reported that the company will invest approximately 310 billion yen in the mass production of the next-generation Solar Cells "Perovskite Type" and is planning to construct a new factory in Sakai City. Operations are scheduled to commence by 2030, and the production capacity is expected to be around 1 million kW in power generation capacity for the batteries. This seems equivalent to the power generation capacity of one Nuclear Power plant. The government is likely to subsidize about 160 billion yen, which is half of the investment. Expectations for future market expansion are high.
Ortz --- rebounding, acquiring stocks of Wasabi and Green & Digital Partners and becoming a subsidiary.
The company announced the acquisition of wasabi and Green & Digital Partners stocks to establish subsidiaries. Wasabi's strengths can enhance business development and system development capabilities in the company's AI Solutions business, which is determined to contribute to the improvement of corporate value within the group. Green & Digital Partners aims to separate its SES and DX consulting business, led by wasabi's representative director, Takuji Kuriyama.